Apr 7
|
2 Stocks to Buy if You're Worried About a Recession
|
Apr 7
|
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4
|
Apr 6
|
Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm
|
Apr 4
|
Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.
|
Apr 3
|
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks
|
Apr 1
|
Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?
|
Apr 1
|
Biotech stocks slide as Marks resignation seen being negative for sector
|
Apr 1
|
VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates
|
Apr 1
|
These biotech names aren't facing 'huge concern' from tariffs
|
Mar 31
|
Intellia Focuses on Pipeline Development Amid Stiff Competition
|
Mar 31
|
Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”
|
Mar 31
|
Vertex halts development of diabetes cell therapy after trial failure
|
Mar 14
|
Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?
|
Mar 14
|
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
|
Mar 13
|
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
|
Mar 13
|
GILD vs. VRTX: Which Stock Is the Better Value Option?
|
Mar 12
|
Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know
|
Mar 12
|
Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds
|
Mar 12
|
Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?
|
Mar 12
|
Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?
|